Schedule 13D Amendment No. 2

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

(Amendment No. 2)

 

 

 

NuStar GP Holdings, LLC


(Name of Issuer)

 

Units representing limited liability company interests


(Title of Class of Securities)

 

91914G 10 8


(CUSIP Number)

 

William E. Greehey

2330 North Loop 1604 West

San Antonio, Texas 78248

(210) 918-2000


(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

August 2, 2007


(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided on a prior page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


   SCHEDULE 13D   
CUSIP No. 91914G 10 8      

 

  1  

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

   
                William E. Greehey    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)  
  (a)  ¨  
    (b)  ¨    
  3   SEC USE ONLY  
         
  4   SOURCE OF FUNDS (SEE INSTRUCTIONS)  
                IN (please see Item 3)    
  5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   ¨
         
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Texas    
NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

    7  SOLE VOTING POWER
 
                  5,642,600 units
    8  SHARED VOTING POWER
 
                  0
    9  SOLE DISPOSITIVE POWER
 
                  5,642,600 units
  10  SHARED DISPOSITIVE POWER
 
                  0
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                5,643,562 units1    
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   ¨
         
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                13.28%    
14   TYPE OF REPORTING PERSON  
                PF    

 

1

Includes 962 “Restricted Units” which were granted as phantom units which entitle the holder to receive Units upon vesting and are granted in tandem with distribution equivalent rights (the “Grant”). The Grant was amended in July 2007 to be NuStar GP Holdings, LLC Units granted subject to restrictions. The “Restricted Units” will continue to vest annually in equal increments over a three-year period beginning August 22, 2007.


Item 1. Security and Issuer

This Amendment No. 2 to amends the statement on Schedule 13D filed with the Securities and Exchange Commission on December 14, 2006, as amended on January 4, 2007 (together, “Schedule 13D”), and is being filed by William E. Greehey (the “Reporting Person”). This Amendment No. 2 relates to the units representing limited liability company interests (the “Units”) of NuStar GP Holdings, LLC, a Delaware limited liability company (the “Company”), which has its principal executive offices at 2330 North Loop 1604 West, San Antonio, Texas 78248. This amendment is being filed to update the Reporting Person’s position following the purchase of additional shares. This Amendment No. 2 supplements and, to the extent inconsistent therewith, amends the information set forth in the Schedule 13D.

 

Item 2. Identity and Background

(a) The name of the Reporting Person is William E. Greehey.

(b) The Reporting Person’s address is 2330 North Loop 1604 West, San Antonio, Texas 78248.

(c) The Reporting Person serves as Chairman of the Board of the Company, as well as Chairman of the Board of NuStar GP, LLC. The principal address of the Company and NuStar GP, LLC is 2330 North Loop 1604 West, San Antonio, Texas 78248.

(d) During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) The Reporting Person is a citizen of Texas.

 

Item 3. Source and Amount of Funds or Other Consideration

From April 26, 2007 through May 2, 2007, the Reporting Person acquired an aggregate of 187,600 Units of the Company in a series of transactions in the open market for a total consideration, before broker commissions, of $6,169,278. Additionally, from August 1, 2007 through August 2, 2007, the Reporting Person acquired an aggregate of 300,000 Units of the Company in a series of transactions in the open market for a total consideration, before broker commissions, of $10,469,711. The Reporting Person used his own personal funds to pay for the Units he acquired in these transactions.

 

Item 4. Purpose of Transaction

The Reporting Person acquired the Units reported herein solely for the purpose of investment. The Reporting Person may make additional purchases of Units, either in the open market or in private transactions, depending on the Company’s business, prospects and financial condition, the market for the Units, general economic conditions, money and stock market conditions and other future developments.

 

Item 5. Interest in Securities of the Issuer

After giving effect to the transactions described above:

(a) There were 42,503,303 Units outstanding as of August 1, 2007. The Reporting Person is deemed to be the beneficial owner of 5,643,562 Units, which based on calculations made in accordance with Rule 13d-3 (“Rule 13d-3”) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), represents 13.28% of the total issued and outstanding Units. The above amount includes 962 “Restricted Units” which were granted as


phantom units which entitle the holder to receive Units upon vesting and are granted in tandem with distribution equivalent rights (the “Grant”). The Grant was amended in July 2007 to be NuStar GP Holdings, LLC Units granted subject to restrictions. The “Restricted Units” will continue to vest annually in equal increments over a three-year period beginning August 22, 2007.

The Reporting Person acquired beneficial ownership of the 5,643,562 Units as a result of the transactions described in Item 3.

(b) The Reporting Person has the sole power to vote, or to direct the vote, and the sole power to dispose, or to direct the disposition over 5,643,562 Units.

(c) In the 60 days prior to the date of filing of this statement, the Reporting Person effected the purchases of Units as set forth on Appendix 1, which were effected in the open market and not previously reported on any Schedule 13D filing.

(d) The Reporting Person will have the right to receive distributions from, the power to direct the receipt of distributions from and the right to receive the proceeds from the sale of the Units reported by such person on the cover page of this Statement on Schedule 13D.

(e) Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Not applicable.

 

Item 7. Material to Be Filed as Exhibits

None.


Signatures

After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: August 10, 2007

 

/s/ William E. Greehey

William E. Greehey


Appendix 1

 

Purchases August 1, 2007:

Quantity

 

Price

100

  34.6900

48,100

  34.7000

2,100

  34.7075

2,400

  34.7100

22,400

  34.7200

9,300

  34.7300

1,900

  34.7400

20,900

  34.7500

3,000

  34.7525

3,400

  34.7600

2,500

  34.7700

2,100

  34.7800

2,316

  34.7900

2,784

  34.8000

500

  34.8100

1,200

  34.8200

700

  34.8300

1,650

  34.8400

5,300

  34.8500

400

  34.8600

1,800

  34.8700

300

  34.8800

500

  34.8900

8,400

  34.9000

2,150

  34.9100

12,400

  34.9200

400

  34.9300

1,900

  34.9400

900

  34.9500

300

  34.9600

300

  34.9700

500

  34.9800

200

  34.9900

400

  35.0000
Purchases August 2, 2007  

Quantity

 

Price

2,000

  34.7500

400

  34.7600

1,300

  34.7800

5,800

  34.8000

700

  34.8100

500

  34.8200

200

  34.8300

900

  34.8400

1,900

  34.8500

1,000

  34.8600

500

  34.8700

600

  34.8800

300

  34.8900

1,800

  34.9000


6,700

  34.9025

700

  34.9050

3,200

  34.9100

1,400

  34.9125

24,900

  34.9184

2,700

  34.9200

2,100

  34.9250

300

  34.9300

800

  34.9350

1,800

  34.9400

1,500

  34.9425

1,900

  34.9450

2,100

  34.9500

2,300

  34.9600

4,400

  34.9700

4,600

  34.9800

500

  34.9900

8,800

  35.0000

100

  35.0100

6,800

  35.0200

500

  35.0900

1,400

  35.1000

500

  35.1200

1,400

  35.1400

3,500

  35.1500

100

  35.1600

100

  35.1800

2,898

  35.1848

300

  35.1900

900

  35.2000

100

  35.2400

11,100

  35.2500

1,100

  35.3400

2,100

  35.3500

1,200

  35.3800

2,000

  35.6000

200

  35.6200

100

  35.6300

100

  35.6400

8,300

  35.6500

102

  35.6800

3,000

  35.7000